Asia-Pacific Colorectal Cancer Therapeutics Market Is Expected to Reach $2.9 Billion by 2020; Find New Report
The Colorectal Cancer (CRC) therapeutics market in the four Asia-Pacific (APAC) countries of India, Australia, China and Japan was worth $1.9 billion in 2013 and is expected to grow at a Compound Annual Growth Rate (CAGR) of 6.5% to $2.9 billion by 2020. Japan had the largest market in 2013, with a value of $1.2 billion, or a 65% share of the combined market of the four countries. It was followed by China, with $491m, or 26%; Australia, with $117m,...
View full press release